IO Biotech, Inc. (IOBT) Social Stream
IO BIOTECH INC (IOBT) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering IOBT.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-01-06 | 3 | $21 | $20 | $20.5 | $1.9 | 978.95% |
| 2022-10-12 | 3 | $20 | $15 | $17.5 | $1.9 | 821.05% |
| 2022-11-14 | 4 | $20 | $15 | $17.5 | $1.9 | 821.05% |
| 2022-11-21 | 4 | $20 | $10 | $15 | $1.9 | 689.47% |
| 2023-03-20 | 4 | $20 | $10 | $13.666 | $1.9 | 619.26% |
| 2023-05-12 | 4 | $11 | $10 | $10.333 | $1.9 | 443.84% |
| 2023-05-25 | 4 | $12 | $11 | $11.333 | $1.9 | 496.47% |
| 2023-08-14 | 4 | $10 | $7 | $8.333 | $1.9 | 338.58% |
| 2023-11-14 | 5 | $10 | $7 | $8.75 | $1.9 | 360.53% |
| NA | 2 | $NA | $NA | $NA | $1.9 | NA% |
The Trend in the Analyst Price Target
Over the past 52 weeks, IOBT's average price target has gone down $8.75.
Over the past 42 weeks, IOBT's average upside potential has been 520.72%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-01-24 | 4 | 20 | 10 | 13.666 | 2.87 | 376.17% |
| 2023-03-15 | 4 | 20 | 10 | 13.666 | 2.25 | 507.38% |
| 2023-03-17 | 4 | 20 | 10 | 13.666 | 1.98 | 590.2% |
| 2023-05-25 | 4 | 12 | 11 | 11.333 | 2.01 | 463.83% |
| 2023-09-28 | 5 | 10 | 7 | 8.750 | 1.33 | 557.89% |
IOBT Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 5 | 0 | 0 | 0 | 0 | 5 |
The Trend in the Broker Recommendations
IOBT's average broker recommendation rating improved by 0.33 over the prior 24 months.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- To contextualize these metrics, consider that out of all US stocks, IO BIOTECH INC's upside potential (average analyst target price relative to current price) is higher than 1041.22% of them.
- IOBT has a higher number of analysts covering the stock than 138.44% of all US stocks.
- IOBT has a higher average analyst price target than 174.95% of all US stocks.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, IO BIOTECH INC's variance in analysts' estimates is lower than -135.11% of them.
Stocks similar to IO BIOTECH INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are MYNZ, DERM, and BNOX.
View All Top Stocks by Price Target
Is IOBT a Buy, Hold or Sell? See the POWR Ratings now!